| Importance of side effects in opioid treatment: a trade-off analysis with patients and physicians RS Gregorian Jr, A Gasik, WJ Kwong, S Voeller, S Kavanagh The Journal of Pain 11 (11), 1095-1108, 2010 | 169 | 2010 |
| Evidence suggests a need to rethink social capital and social capital interventions A Shiell, P Hawe, S Kavanagh Social science & medicine 257, 111930, 2020 | 134 | 2020 |
| Cognition, function, and caregiving time patterns in patients with mild-to-moderate Alzheimer disease: a 12-month analysis HH Feldman, B Van Baelen, SM Kavanagh, KEL Torfs Alzheimer Disease & Associated Disorders 19 (1), 29-36, 2005 | 133 | 2005 |
| Needlestick injuries: incidence and cost in the United States, United Kingdom, Germany, France, Italy, and Spain M Saia, F Hofmann, J Sharman, D Abiteboul, M Campins, J Burkowitz, ... Biomed Int 1 (2), 41-49, 2010 | 103 | 2010 |
| Opening new doors M Donnelly, S McGilloway, N Mays, S Perry, M Knapp, S Kavanagh, ... HMSO, 1994 | 91 | 1994 |
| The impact on general practitioners of the changing balance of care for elderly people living in institutions S Kavanagh, M Knapp Bmj 317 (7154), 322-327, 1998 | 87 | 1998 |
| The effects of galantamine treatment on caregiver time in Alzheimer's disease M Sano, GK Wilcock, B van Baelen, S Kavanagh International journal of geriatric psychiatry 18 (10), 942-950, 2003 | 79 | 2003 |
| Treatment with galantamine and time to nursing home placement in Alzheimer's disease patients with and without cerebrovascular disease HH Feldman, T Pirttila, JF Dartigues, B Everitt, B Van Baelen, S Schwalen, ... International Journal of Geriatric Psychiatry: A journal of the psychiatry …, 2009 | 76 | 2009 |
| A comparison of the cost-effectiveness of sertraline versus tricyclic antidepressants in primary care J Forder, S Kavanagh, A Fenyo Journal of affective disorders 38 (2-3), 97-111, 1996 | 75 | 1996 |
| A comparison of the cost-effectiveness of sertraline versus tricyclic antidepressants in primary care J Forder, S Kavanagh, A Fenyo Journal of affective disorders 38 (2-3), 97-111, 1996 | 75 | 1996 |
| Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain WJ Kwong, J Diels, S Kavanagh Annals of Pharmacotherapy 44 (4), 630-640, 2010 | 66 | 2010 |
| Elderly people with cognitive impairment: costing possible changes in the balance of care S Kavanagh, J Schneider, M Knapp, JB BA, A Netten Health & Social Care in the Community 1 (2), 69-80, 1993 | 62 | 1993 |
| Galantamine and behavior in Alzheimer disease: analysis of four trials S Kavanagh, M Gaudig, B Van Baelen, M Adami, A Delgado, C Guzman, ... Acta neurologica scandinavica 124 (5), 302-308, 2011 | 58 | 2011 |
| Economic outcomes and costs in the treatment of schizophrenia M Knapp, S Kavanagh Clinical therapeutics 19 (1), 128-138, 1997 | 56 | 1997 |
| Schizophrenia: shifting the balance of care S Kavanagh, L Opit, M Knapp, J Beecham Social Psychiatry and Psychiatric Epidemiology 30, 206-212, 1995 | 53 | 1995 |
| Elderly people with advanced cognitive impairment in England: Resource use and costs J Schneider, S Kavanagh, M Knapp, J Beecham, A Netten Ageing & Society 13 (1), 27-50, 1993 | 53 | 1993 |
| Costs and disability among stroke patients S Kavanagh, M Knapp, A Patel Journal of Public Health 21 (4), 385-394, 1999 | 50 | 1999 |
| Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimer’s Disease: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial S Aronson, B Van Baelen, S Kavanagh, S Schwalen Drugs & aging 26, 231-239, 2009 | 47 | 2009 |
| Cognitive disability and direct care costs for elderly people S Kavanagh, M Knapp The British Journal of Psychiatry 174 (6), 539-546, 1999 | 40 | 1999 |
| Long-term treatment of patients with Alzheimer's disease in primary and secondary care: results from an international survey L Froelich, N Andreasen, M Tsolaki, A Foucher, S Kavanagh, ... Current Medical Research and Opinion 25 (12), 3059-3068, 2009 | 37 | 2009 |
Martin KnappLondon School of Economics and Political ScienceVerified email at lse.ac.uk
